Year: 2025
Type: article
Abstract: This article describes three advancements in sarcoma care in the past year, including a trial supporting immunotherapy in specific soft tissue sarcomas, Food and Drug Administration approval of a T‐cell therapy for synovial sarcoma, and long‐term efficacy data for a gamma‐secretase inhibitor in desmoid tumors. These advances represent a shift toward more effective, targeted treatments across a variety of challenging tumors.
Source: Cancer
DOI: 10.1002/cncr.35965
Authors: Mason Vierra, Jamie Brett, Jiping Wang
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4411762751